Document is current
Any future updates will be listed below
-
Authors
Bodac, Anita
Mayet, Abdullah
Rana, Sarika
Pascual, Justine
Bowler, Amber D https://orcid.org/0000-0002-9439-2839
Roh, Vincent
Fournier, Nadine https://orcid.org/0000-0002-9347-7929
Craciun, Ligia
Demetter, Pieter
Radtke, Freddy https://orcid.org/0000-0003-4315-4045
Meylan, Etienne https://orcid.org/0000-0002-0899-2230
-
Funding
Funding for this research was provided by:
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (310030_179324)
Chercher et Trouver Foundation
Fonds De La Recherche Scientifique - FNRS (MISU F.6003.22)
Fonds De La Recherche Scientifique - FNRS (TLV - 7.4574.21)
ULB Actions de Recherche Concertees
Fonds Jean Brachet
Association Jules Bordet
- License Information
-
More Information
Article History
Received: 28 June 2023
Revised: 24 November 2023
Accepted: 28 November 2023
First Online: 20 December 2023
Disclosure and competing interests statement
: FR is a co-founder of Cellestia. EM serves in the scientific advisory board of InhaTarget Therapeutics. The remaining authors declare no competing interests.
